IP Verse

Acerta Pharma B.V. V. Cipla Limited - 1:24-cv-00587

Explore the details of the Acerta Pharma B.V. V. Cipla Limited case under case number 1:24-cv-00587 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00587
Filing Date
May 16, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
MSN Laboratories Private Ltd. -
Cipla Limited -
AstraZeneca Pharmaceuticals LP -
Acerta Pharma B.V. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

May 22, 2025STIPULATION TO EXTEND TIME the deadline for the parties to submit their Joint Claim Construction Chart to May 28, 2025 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) (Entered: 05/22/2025)PACER Document
May 28, 2025CLAIM Construction Chart by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: # 1 Exhibit 1-16)(Silver, Daniel) (Entered: 05/28/2025)PACER Document
May 30, 2025NOTICE OF SERVICE of First Set of Requests for the Production of Documents and Things (Nos. 1-118) filed by Cipla Limited, Cipla USA, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Goeller, Matthew) (Entered: 05/30/2025)PACER Document
Jun 2, 2025NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production to Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited (Nos. 1-82) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited.(Silver, Daniel) (Entered: 06/02/2025)PACER Document
Jun 2, 2025NOTICE OF SERVICE of Defendants Initial Invalidity Contentions and accompanying documents filed by Cipla Limited, Cipla USA, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Goeller, Matthew) (Entered: 06/02/2025)PACER Document
Jun 23, 2025NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief, Supporting Expert Declaration, and Exhibits filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited.(Silver, Daniel) (Entered: 06/23/2025)PACER Document
Jul 10, 2025NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' First Set of Requests for the Production of Documents and Things (Nos. 1-118) filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited.(Joyce, Alexandra) (Entered: 07/10/2025)PACER Document
Jul 16, 2025STIPULATION TO EXTEND TIME of Certain Deadlines in the Case Schedule for Claim Construction Briefing to See Stip for Details - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Joyce, Alexandra) (Entered: 07/16/2025)PACER Document
Jul 16, 2025NOTICE OF SERVICE of MSN Pharmaceuticals Inc. And MSN Laboratories Private Limited Objections And Responses To Plaintiffs' First Set Of Requests For Production To Defendants MSN Pharmaceuticals Inc. And MSN Laboratories Private Limited Nos. 1-82 filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Green, James) (Entered: 07/16/2025)PACER Document
Jul 16, 2025STIPULATION and [Proposed] Order Regarding Infringement and Discovery of MSN by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Joyce, Alexandra) (Entered: 07/16/2025)PACER Document
May 23, 2025SO ORDERED, re 38 STIPULATION TO EXTEND TIME the deadline for the parties to submit their Joint Claim Construction Chart to May 28, 2025 filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, AstraZeneca AB, Acerta Pharma B.V. Signed by Judge Gregory B. Williams on 5/23/2025. (lnb)PACER Document
May 23, 2025SO ORDERED, re 39 STIPULATION TO EXTEND TIME the deadline for the parties to submit a joint technology tutorial to September 19, 2025 filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, AstraZeneca AB, Acerta Pharma B.V. Signed by Judge Gregory B. Williams on 5/23/2025. (lnb)PACER Document
Jul 17, 2025SO ORDERED, re 46 STIPULATION TO EXTEND TIME of Certain Deadlines in the Case Schedule for Claim Construction Briefing to See Stip for Details filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, AstraZeneca AB, Acerta Pharma B.V. Signed by Judge Gregory B. Williams on 7/17/2025. (lnb)PACER Document
Jul 17, 2025SO ORDERED, re 47 Stipulation Regarding Infringement and Discovery of MSN filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, AstraZeneca AB, Acerta Pharma B.V. Signed by Judge Gregory B. Williams on 7/17/2025. (lnb)PACER Document
May 28, 2025CLAIM Construction Chart by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: # 1 Exhibit 1-16)(Silver, Daniel) (Entered: 05/28/2025)Attachment
Jul 28, 2025NOTICE OF SERVICE of Defendants Cipla Limited and Cipla USA, Inc.'s Answering Claim Construction Brief filed by Cipla Limited, Cipla USA, Inc..(Goeller, Matthew) (Entered: 07/28/2025)PACER Document
Aug 5, 2025NOTICE to Take Deposition of Joseph H. Reibenspies, Ph.D. on August 8, 2025 filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited.(Silver, Daniel) (Entered: 08/05/2025)PACER Document